Home
Centre for Cancer Biomarkers CCBIO

Oslo Cancer Cluster R&D Network meeting

The Oslo Cancer Cluster team are happy to invite you to an R&D Network on personalized cancer medicine – this time seen from the legal and ethical view, as well as touching upon the societal implications of personalized medicine and the investor perspective.

Main content

Time: Wednesday December 9th, kl 14.00-17.30

Venue: Kaare Norum aud. (2nd floor, entrance 2B), Oslo Cancer Cluster Innovation park, Ullernchausséen 64, Oslo

 

PLEASE SIGN UP BY DECEMBER 5thHERE

 

PROGRAM

14:00–14:30 Registration and coffee

 

14:30–14:45 Welcome and update

Ketil Widerberg, general manager Oslo Cancer Cluster

 

14:45–15:15 Norwegian Cancer Genomics Consortium – an update

Ola Myklebost, Norwegian Cancer Genomics Consortium

 

15:15–15:40 Oncoimmunity - design & guiding in personalized medicine

Richard Stratford, Oncoimmunity

 

15:40–16:00 Ethical and societal implications of personalized medicine

Sigrid Thoresen, senior advisor, The Norwegian Biotechnology Advisory Board

 

16:00–16:20 Legal regulation of personalized cancer medicine

Heidi Beate Bentzen , PhD Candidate, Centre for Medical Ethics and The Norwegian Research Center for Computers and Law, University of Oslo

 

16:20–16:40 Personalized cancer medicine – the investor’s perspective

Johan Christenson, Partner, HealthCap

 

16:40 Networking with light refreshments

 

We look forward to an interesting meeting!

Any questions, please contact mbl@oslocancercluster.no